The Etiology of Metabolic Disturbances in Schizophrenia : Drugs, Genes, and Environment
| Errataetall: |
CommentOn: Int J Neuropsychopharmacol. 2021 May 18;24(5):367-382. - PMID 33315097 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
|---|---|
| Enthalten in: |
The international journal of neuropsychopharmacology - 24(2021), 10 vom: 23. Okt., Seite 854-855 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Reynolds, Gavin P [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antipsychotic Agents |
|---|
| Anmerkungen: |
Date Completed 23.11.2021 Date Revised 23.11.2021 published: Print CommentOn: Int J Neuropsychopharmacol. 2021 May 18;24(5):367-382. - PMID 33315097 Citation Status MEDLINE |
|---|
| doi: |
10.1093/ijnp/pyab047 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM327979704 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM327979704 | ||
| 003 | DE-627 | ||
| 005 | 20231225202003.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/ijnp/pyab047 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1093.xml |
| 035 | |a (DE-627)NLM327979704 | ||
| 035 | |a (NLM)34252192 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Reynolds, Gavin P |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The Etiology of Metabolic Disturbances in Schizophrenia |b Drugs, Genes, and Environment |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.11.2021 | ||
| 500 | |a Date Revised 23.11.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: Int J Neuropsychopharmacol. 2021 May 18;24(5):367-382. - PMID 33315097 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Antipsychotic Agents |2 NLM | |
| 650 | 7 | |a Pharmaceutical Preparations |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t The international journal of neuropsychopharmacology |d 1995 |g 24(2021), 10 vom: 23. Okt., Seite 854-855 |w (DE-627)NLM097537578 |x 1469-5111 |7 nnns |
| 773 | 1 | 8 | |g volume:24 |g year:2021 |g number:10 |g day:23 |g month:10 |g pages:854-855 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/ijnp/pyab047 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 24 |j 2021 |e 10 |b 23 |c 10 |h 854-855 | ||